ArticlebioRxiv : the preprint server for biology2025

Unlocking the Power of CXCR2 Inhibition to Overcome Gemcitabine Resistance in Pancreatic Cancer.

Caitlin Molczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.